88 related articles for article (PubMed ID: 19468271)
1. Impact of new prognostic markers in treatment decisions in acute myeloid leukemia.
Schlenk RF; Döhner K
Curr Opin Hematol; 2009 Mar; 16(2):98-104. PubMed ID: 19468271
[TBL] [Abstract][Full Text] [Related]
2. Targeted Therapy Development in Acute Myeloid Leukemia.
Totiger TM; Ghoshal A; Zabroski J; Sondhi A; Bucha S; Jahn J; Feng Y; Taylor J
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831175
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome and prognosis of patients with acute myeloid leukemia submitted to chemotherapy with 5 years of follow-up.
Albuquerque KMC; Joventino CB; Moreira LC; Rocha HAL; Gurgel LA; Oliveira DS; Rodrigues CEM
Hematol Transfus Cell Ther; 2024; 46(1):8-13. PubMed ID: 36564332
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor.
James AJ; Smith CC; Litzow M; Perl AE; Altman JK; Shepard D; Kadokura T; Souda K; Patton M; Lu Z; Liu C; Moy S; Levis MJ; Bahceci E
Clin Pharmacokinet; 2020 Oct; 59(10):1273-1290. PubMed ID: 32304015
[TBL] [Abstract][Full Text] [Related]
5. CD105 (Endoglin) as negative prognostic factor in AML.
Kauer J; Schwartz K; Tandler C; Hinterleitner C; Roerden M; Jung G; Salih HR; Heitmann JS; Märklin M
Sci Rep; 2019 Dec; 9(1):18337. PubMed ID: 31797971
[TBL] [Abstract][Full Text] [Related]
6. Increased
Li XX; Zhou JD; Wen XM; Zhang TJ; Wu DH; Deng ZQ; Zhang ZH; Lian XY; He PF; Yao XY; Lin J; Qian J
Onco Targets Ther; 2019; 12():3295-3304. PubMed ID: 31118680
[No Abstract] [Full Text] [Related]
7. Frontline treatment of acute myeloid leukemia in adults.
Tamamyan G; Kadia T; Ravandi F; Borthakur G; Cortes J; Jabbour E; Daver N; Ohanian M; Kantarjian H; Konopleva M
Crit Rev Oncol Hematol; 2017 Feb; 110():20-34. PubMed ID: 28109402
[TBL] [Abstract][Full Text] [Related]
8. RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells.
Gianni M; Fratelli M; Bolis M; Kurosaki M; Zanetti A; Paroni G; Rambaldi A; Borleri G; Rochette-Egly C; Terao M; Garattini E
Oncotarget; 2017 Jun; 8(23):37041-37060. PubMed ID: 27419624
[TBL] [Abstract][Full Text] [Related]
9. Therapy-related acute myeloid leukemia in patients with lymphoma: A report of four cases and review of the literature.
Yang D; Fu X; Zhang X; Li W; Zhang M
Oncol Lett; 2015 Nov; 10(5):3261-3265. PubMed ID: 26722322
[TBL] [Abstract][Full Text] [Related]
10. Effect of NPM1 and FLT3 mutations on the outcomes of elderly patients with acute myeloid leukemia receiving standard chemotherapy.
Daver N; Liu Dumlao T; Ravandi F; Pierce S; Borthakur G; Pemmaraju N; Nazha A; Faderl S; Jabbour E; Garcia-Manero G; Cortes J; Kantarjian H; Quintás-Cardama A
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):435-40. PubMed ID: 23763915
[TBL] [Abstract][Full Text] [Related]
11. Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
Herrmann H; Blatt K; Shi J; Gleixner KV; Cerny-Reiterer S; Müllauer L; Vakoc CR; Sperr WR; Horny HP; Bradner JE; Zuber J; Valent P
Oncotarget; 2012 Dec; 3(12):1588-99. PubMed ID: 23249862
[TBL] [Abstract][Full Text] [Related]
12. Cell of origin determines clinically relevant subtypes of MLL-rearranged AML.
Krivtsov AV; Figueroa ME; Sinha AU; Stubbs MC; Feng Z; Valk PJ; Delwel R; Döhner K; Bullinger L; Kung AL; Melnick AM; Armstrong SA
Leukemia; 2013 Apr; 27(4):852-60. PubMed ID: 23235717
[TBL] [Abstract][Full Text] [Related]
13. Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: effect of specimen source (bone marrow or peripheral blood) on assay readouts.
Cesano A; Rosen DB; O'Meara P; Putta S; Gayko U; Spellmeyer DC; Cripe LD; Sun Z; Uno H; Litzow MR; Tallman MS; Paietta E
Cytometry B Clin Cytom; 2012 May; 82(3):158-72. PubMed ID: 22334473
[TBL] [Abstract][Full Text] [Related]
14. Treatment of elderly acute myeloid leukemia patients.
Motyckova G; Stone RM
Curr Treat Options Oncol; 2011 Dec; 12(4):341-53. PubMed ID: 21901552
[TBL] [Abstract][Full Text] [Related]
15. ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients.
Marzac C; Garrido E; Tang R; Fava F; Hirsch P; De Benedictis C; Corre E; Lapusan S; Lallemand JY; Marie JP; Jacquet E; Legrand O
Haematologica; 2011 Sep; 96(9):1293-301. PubMed ID: 21606172
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia with IDH1 or IDH2 mutation: frequency and clinicopathologic features.
Patel KP; Ravandi F; Ma D; Paladugu A; Barkoh BA; Medeiros LJ; Luthra R
Am J Clin Pathol; 2011 Jan; 135(1):35-45. PubMed ID: 21173122
[TBL] [Abstract][Full Text] [Related]
17. Mutations in AML with a normal karyotype: NPM1 and FLT3-ITD, ready to use as a key prognosticator?
Kim HJ
Korean J Hematol; 2010 Jun; 45(2):79-80. PubMed ID: 21120181
[No Abstract] [Full Text] [Related]
18. Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy.
Ravandi F; Cortes J; Faderl S; O'Brien S; Garcia-Manero G; Verstovsek S; Santos FP; Shan J; Brandt M; de Lima M; Pierce S; Kantarjian H
Blood; 2010 Dec; 116(26):5818-23; quiz 6153. PubMed ID: 20923968
[TBL] [Abstract][Full Text] [Related]
19. Distinct patterns of DNA damage response and apoptosis correlate with Jak/Stat and PI3kinase response profiles in human acute myelogenous leukemia.
Rosen DB; Putta S; Covey T; Huang YW; Nolan GP; Cesano A; Minden MD; Fantl WJ
PLoS One; 2010 Aug; 5(8):e12405. PubMed ID: 20811632
[TBL] [Abstract][Full Text] [Related]
20. Integrative meta-analysis of differential gene expression in acute myeloid leukemia.
Miller BG; Stamatoyannopoulos JA
PLoS One; 2010 Mar; 5(3):e9466. PubMed ID: 20209125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
